Stock·NASDAQ·Technology
AST SpaceMobile Inc. (ASTS)
- Market cap
- $15.82B
- Dividend yield
- 0.00%
- Street target
- $79.00median of 13 analysts
- 52-week range
- $39.87 $133.86
The short version
Where ASTS stands today, in four lines, and what CleaRank Financial AI makes of it.
ASTS at a glance
AST SpaceMobile Inc. (ASTS): Sell, 29/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($60.79 and $79.97).
- Earnings ASTS beat estimates in 2 of its last 8 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $459.4M and bought $806K over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates AST SpaceMobile Inc. (ASTS) Sell, with a model score of 29/100.
Revenue growth lifts the score most: revenue grew 2,626.60%, 2,602.4 percentage points faster than the sector median. The trend holds it back most: the price is 49.16% below its 200-day average and 33.12% below its 50-day average, and the 50-day average is 23.98% below the 200-day. The 50-day average stands at $60.79 and the 200-day at $79.97. Over the past year the price fell 54.57%.
Only on CleaRank
Figures we compute ourselves from ASTS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $40.66 is 33.1% below the 50-day simple moving average of $60.79.Price above its 200-day average ›
The price is 49.2% below the 200-day simple moving average of $79.97.50-day average above the 200-day ›
The 50-day average ($60.79) is 24.0% below the 200-day average ($79.97), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 1% of its 52-week range, between $39.87 and $133.86.
ASTS share price
Pick a period: each tab shows how far ASTS has moved over it, to the last close.
Today's trading
Where ASTS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/3P/S below the sector median ›
The price-to-sales ratio of 145.14 is 1,809.7% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $-618.8M on revenue of $115.3M, a net margin of -536.7%.Beat estimates in most recent reports ›
ASTS beat the EPS estimate in 2 of its last 8 reports.
Key statistics
The headline figures for ASTS.
As of October 17, 2026, ASTS trades at $40.66, with a market value of $15.82B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of ASTS's valuation, growth and risks.
Earnings do not give ASTS a usable P/E, which is not meaningful because the company lost money over the last 12 months. Measured on sales, the P/S of 145.14 is 1,809.7% above the sector median of 7.6. To put the size in context, the market value is $15.8B, and trailing earnings are -$2.13 a share.
ASTS is loss-making. Its net margin is -536.66% and its operating margin is -544.63%, while return on equity of -45.62% sits below the sector median of 13.4%. Revenue rose 2,626.60% in the latest year, which is 2,602.4 percentage points faster than the sector median of 24.2%. Debt-to-equity stands at 1.25.
The August 10, 2026 report missed expectations by 133.33%: EPS of -$0.77 against an estimate of -$0.33. The stock still rose 4.17% in the next session.
ASTS has beaten estimates in 2 of the last 8 reports, yet the stock still fell in the first session after 1 of those 2 beats. Analysts expect EPS of -$2.28 for this fiscal year and -$1.19 for the next.
ASTS typically moves about 5.04% in a day. While the price stays beneath both moving averages, the downtrend remains a risk in its own right. The price is 69.62% below the 52-week high of $133.86. Insider sales over the last 18 months totalled $459.4M, while insider purchases came to $806K. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than buying does.
ASTS against the Technology sector
How ASTS compares with the median Technology stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, ASTS trades at 145.14x, far above the sector average of 7.60x.
Return vs XLK: Since May 6, 2025, ASTS has gained 62.1% against a gain of 71.7% for XLK.
Performance against XLK
ASTS and the Technology sector fund over the same days.
Revenue and earnings
How much ASTS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 1,505.2% in FY2025 to $70.9M, from $4.4M a year earlier.
Profit margin: The net margin was -650.1% in FY2025, up from -11,913.3% the year before.
Loss-making: ASTS lost $461M in FY2025.
Earnings reality check
Did ASTS beat what analysts expected, and how did the stock react?
Earnings record: ASTS beat the analyst estimate in 2 of the last 8 quarters.
Market reaction: The stock fell in the first session after 1 of those 2 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 10, 2026after close | -$0.33 | -$0.77 | -133.33% | +4.17% | +3.46% |
| Mar 2, 2026after close | -$0.20 | -$0.26 | -30.00% | +6.63% | +3.27% |
| Nov 10, 2025after close | -$0.26 | -$0.45 | -73.08% | -1.18% | -17.61% |
| Aug 11, 2025after close | -$0.22 | -$0.41 | -86.36% | +8.36% | +4.88% |
| May 12, 2025after close | -$0.22 | -$0.20 | +9.09% | -2.25% | -9.39% |
| Mar 3, 2025after close | -$0.18 | -$0.12 | +33.33% | +11.67% | +13.74% |
| Nov 14, 2024after close | -$0.20 | -$1.10 | -450.00% | -9.59% | -9.93% |
| Aug 14, 2024after close | -$0.22 | -$0.51 | -131.82% | +50.70% | +75.11% |
As of October 17, 2026, ASTS has beaten the analyst EPS estimate in 2 of its last 8 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 10, 2026, came in 133.33% below the estimate and the stock moved +4.17% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 29.1, in oversold territory.RSI above 50 ›
An RSI of 29.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of ASTS
The score, the reasoning behind it, and what could move the price next.
Both moving averages sit above the price, the shape of a downtrend for ASTS: the price of $40.66 is 33.12% below the 50-day average ($60.79) and 49.16% below the 200-day average ($79.97). At 1% of its 52-week range, the price is 1.98% above the 52-week low of $39.87. The 50-day average runs 23.98% below the 200-day average, so the shorter trend is weaker than the longer one.
On momentum, the 14-day RSI reads 29.1, in oversold territory, with the MACD line negative. Every period on the chart shows a loss, with the price down 29.65% over the past three months, 52.46% over the past six months and 54.57% over the past year.
Earnings miss ›
The August 10, 2026 report missed the EPS estimate by 133.33%, and the share price rose 4.17% in the first session after it.
Source: Earnings report, August 10, 2026New analyst coverage ›
Berenberg started coverage at Buy on September 2, 2026.
Source: Analyst action, Berenberg, September 2, 2026
Analyst downgrade ›
B. Riley Securities downgraded it to Neutral from Buy on October 2, 2026.
Source: Analyst action, B. Riley Securities, October 2, 2026
- The two nearest levels to watch are the 20-day EMA at $53.58, which is above the price, and the 52-week low at $39.87, which is below it.
- A 14-day RSI of 29.1 places the momentum in the oversold zone, and the MACD line is negative. Readings above 70 or below 30 point to stretched momentum.
- The share price climbed 4.17% in the first session after the August 10, 2026 report. Over the last 8 reports, ASTS beat estimates in 2 of them.
ASTS remains in a downtrend while it trades below both its 50-day average of $60.79 and its 200-day average of $79.97. A close back above the 50-day would be the first sign of a repair. The 20-day EMA, at $53.58, is the first hurdle above the price.
The next level below the price is the 52-week low of $39.87.
Technical indicators
Momentum and trend for ASTS, from its daily closes.
As of October 17, 2026, with ASTS at $40.66, its 14-day RSI is 29.1 (oversold territory), its 50-day simple moving average is $60.79 and its 200-day is $79.97.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What ASTS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, ASTS's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.45 with Nasdaq 100 (QQQ), +0.32 with Bitcoin (BTC) and +0.19 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
4 of 13 analysts rate it a buy or strong buy, 7 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $79.00 is 94.3% above the price.More buy ratings than three months ago ›
4 of 13 rate it a buy now, against 4 of 13 three months ago.
ASTS Wall Street View
12-month price targets
The price, $40.66, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 2, 2026 | B. Riley Securities | Downgrade | Neutral |
| Sep 2, 2026 | Berenberg | Initiates | Buy |
| Aug 11, 2026 | UBS | Maintains | Neutral |
| Aug 11, 2026 | Piper Sandler | Maintains | Overweight |
| Aug 11, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Jul 29, 2026 | Scotiabank | Upgrade | Sector Perform |
As of October 17, 2026, 13 Wall Street analysts cover ASTS: 4 rate it a buy or strong buy, 7 a hold and 2 a sell or strong sell. Their 12-month price targets range from $42.50 to $108.00, with a median of $79.00, 94.3% above the price of $40.66.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
ASTS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
ASTS moves about 5.0% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much ASTS tends to move, against the market and on its own.
The long record
ASTS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 5.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 90.4%, from February 2021 to April 2024, regained by August 2024.Most 1-year holds ended higher ›
58% of 1-year holding periods in the last 7 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in November 2019 is now worth $41,617, against $27,544 in the S&P 500 (SPY).
ASTS Drawdowns & Recovery
As of October 17, 2026, ASTS's worst peak-to-trough fall over the last 7 years with dividends reinvested was -90.4% (February 2021 to April 2024); it regained that peak by August 2024, 4 months after the low, and 58% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into ASTS in November 2019 is worth now, against the same amount in the S&P 500.
Against the market: ASTS beat the S&P 500 over this period: $41,617 against $27,544.
A $10,000 investment in ASTS in November 2019 would be worth about $41,617 today with dividends reinvested, compared with about $27,544 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to ASTS, and which have not.
Strongest month, May: an average of +46.91%, up in 4 of 7 years.
Weakest month, April: an average of -18.19%, up in 1 of 7 years.
This month, October: has averaged +5.08%, up in 2 of 6 years. Past seasonality does not repeat on schedule.
Over the last 7 years, ASTS's strongest calendar month has been May (average +46.91%, up in 4 of 7 years) and its weakest April (average -18.19%, up in 1 of 7 years).
Average return for each calendar month over the last 7 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in ASTS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ASTS today could grow to about $27,497 by 2036 in the base case, with a 90th-percentile outcome near $208,611 and a 10th-percentile outcome around $3,624. Projections are statistical simulations, not guarantees.
ASTS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $60.94 for ASTS by 2030 in the base case, from $40.66 today (1.5x over 4 years). The 10th-percentile path ends near $16.92. These are outcomes of a Monte Carlo simulation run on ASTS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $23.70 | $44.99 | $85.39 | |
| 2028 | $20.11 | $49.78 | $123 | |
| 2029 | $18.15 | $55.07 | $167 | |
| 2030 | $16.92 | $60.94 | $220 | |
| 2031 | $16.09 | $67.42 | $283 |
Method: a lognormal simulation of ASTS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. ASTS is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
ASTS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $806K on the open market and sold $459.4M.
As of October 17, 2026, ASTS insiders reported 21 open-market sales worth $459.4M and 5 open-market purchases worth $806K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $2.4M |
| Sep 16, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 12.0K | $706.7K |
| Aug 31, 2026 | Adriana Cisneros
Director
|
Buy | 10.8K | $619.2K |
| Aug 19, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Aug 17, 2026 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 150.0K | - |
| Aug 17, 2026 | Maya Bernal
Officer
|
Grant | 20.0K | - |
| Aug 17, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 75.0K | - |
| Aug 17, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 75.0K | - |
| Aug 17, 2026 | Scott Wisniewski
President
|
Grant | 75.0K | - |
| Jun 12, 2026 | Adriana Cisneros
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Ronald L Rubin
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Richard Sarnoff
Director
|
Grant | 2.1K | - |
| Jun 12, 2026 | Julio A Torres
Director
|
Grant | 2.1K | - |
| Jun 11, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 45.8K | $4.3M |
| Jun 5, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $3.9M |
| May 22, 2026 | Huiwen Yao
Chief Technology Officer
|
Grant | 30.0K | - |
| May 20, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 5.0K | $451.3K |
| May 19, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| May 18, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 66.7K | - |
| May 13, 2026 | Julio A Torres
Director
|
Sell | 15.0K | $1.1M |
| Apr 15, 2026 | Hiroshi Mikitani
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 3.0M | $270.9M |
| Mar 24, 2026 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 184.4K | - |
| Mar 24, 2026 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 54.7K | - |
| Mar 24, 2026 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 100.0K | - |
| Mar 24, 2026 | Scott Wisniewski
President
|
Grant | 123.4K | - |
| Mar 23, 2026 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $3.6M |
| Mar 11, 2026 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Dec 24, 2025 | Keith R Larson
Director
|
Buy | 625 | $50.0K |
| Dec 17, 2025 | Keith R Larson
Director
|
Buy | 715 | $50.1K |
| Dec 10, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 10.0K | $773.4K |
| Dec 10, 2025 | Keith R Larson
Director
|
Buy | 675 | $49.1K |
| Dec 9, 2025 | American Tower Corporation
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 2.3M | $159.6M |
| Dec 5, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $2.9M |
| Dec 5, 2025 | Maya Bernal
Officer
|
Sell | 6.0K | $442.6K |
| Dec 2, 2025 | Abel Antonio Avellan
Chief Executive Officer
|
Grant | 250.0K | - |
| Dec 2, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Grant | 125.0K | - |
| Dec 2, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 125.0K | - |
| Dec 2, 2025 | Scott Wisniewski
President
|
Grant | 125.0K | - |
| Nov 26, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 10.0K | $560.0K |
| Nov 20, 2025 | Adriana Cisneros
Director
|
Buy | 750 | $38.1K |
| Nov 14, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Sep 16, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 40.0K | $1.6M |
| Sep 3, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 16.0K | $768.6K |
| Sep 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 40.0K | $2.6K |
| Aug 26, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Sell | 20.0K | $1.0M |
| Aug 15, 2025 | Andrew Martin Johnson
Chief Financial Officer
|
Grant | 93.8K | - |
| Aug 15, 2025 | Scott Wisniewski
President
|
Grant | 93.8K | - |
| Jun 24, 2025 | Adriana Cisneros
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Ronald L Rubin
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Richard Sarnoff
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Julio A Torres
Director
|
Grant | 801 | - |
| Jun 24, 2025 | Johan Wibergh
Director
|
Grant | 801 | - |
| Jun 16, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 10.0K | $418.4K |
| Jun 10, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 4.3K | $147.1K |
| Jun 9, 2025 | Scott Wisniewski
President
|
Sell | 50.0K | $1.8M |
| Jun 9, 2025 | Shanti B. Gupta
Chief Operating Officer
|
Sell | 15.0K | $541.2K |
| Jun 6, 2025 | Adriana Cisneros
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Ronald L Rubin
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Richard Sarnoff
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Julio A Torres
Director
|
Grant | 4.8K | - |
| Jun 6, 2025 | Johan Wibergh
Director
|
Grant | 4.8K | - |
| Jun 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Option | 25.0K | $603.8K |
| Jun 2, 2025 | Huiwen Yao
Chief Technology Officer
|
Grant | 25.0K | - |
| May 30, 2025 | Maya Bernal
Officer
|
Grant | 20.0K | - |
| May 16, 2025 | Huiwen Yao
Chief Technology Officer
|
Sell | 55.0K | $1.5M |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.